Diabetes

01 Jul 2015  |  North America

Analysis of the US and European Diabetes Diagnostics Market

Constricting Reimbursement Policies Restrain Market Growth

Infographics

×

The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...

The marketed and development product landscape for diabetes therapeutics is becoming crowded with multiple products with little differentiation. However, there is still ample room for growth through the introduction of novel therapies that fill therapeutic gaps left by available products. Comprehensive information on market background and global ...

This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90...

A majority of type 2 diabetics currently use Lantus SoloSTAR Pen. Most of them use prefilled injection pens that are entirely disposable. These pens are more convenient to use for most patients with busy lifestyles, as they come pre-filled with insulin/medication. Easy push-button injection, transparent cartridge, and a window showing injection is ...

Type 2 diabetes is the most common form of diabetes. It is a chronic disease marked by high levels of glucose in the blood. The primary goal to treat type 2 diabetes is diet and exercise. However, if diet and exercise does not help maintain normal glucose levels, physicians may prescribe medication. A sample size of 1,002 adult type 2 diabetes p...

This study encompasses feedback provided by U.S. diabetes patients on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Data was presented for the general objective point questions as well as analysis by disease subtype where applicable. Patient feedback about ...

This study encompasses feedback provided by U.S. physicians who treat diabetes on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Analysis includes issues such as awareness, usage, preferences, influencing criteria, patient compliance, desired delivery types ...

This research services details the market drivers, restraints, challenges, revenue forecasts of the insulin and the no-insulin market segments of the global diabetes market. It also deals with regional analysis of the US, Europe, Japan and rest of the world markets.

Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep increasing the potential for this market. Consequently increasingly more brands and products have been introduced into this market, splitting the diabetes therapy business in three...